Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Juan Gomez

Geriatric Medicine Coral Gables, FL Medical Doctor

NPI 1477996213 CMS profile 2782177

2601 Sw 37Th Ave Ste 904, Coral Gables, FL 33133

Open in the dashboard

General payments

$352

6 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Juan Gomez of Coral Gables, FL is reported in the CMS Open Payments database as having received $352 across 6 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $184 3
2022 General $125 1
2021 General $17 1
2019 General $25 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Juan Gomez
  • Geriatric Medicine median
  • Middle half of Geriatric Medicine
  • National median

In program year 2025, general payments to Juan Gomez were reported at $0. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.

Show as a table
Year Juan Gomez Geriatric Medicine median Middle half National median
2019 $25 $96 $28–$339 $163
2020 $0 $99 $28–$262 $114
2021 $17 $94 $27–$318 $132
2022 $125 $103 $34–$338 $149
2023 $184 $109 $39–$320 $160
2024 $0 $125 $36–$371 $164
2025 $0 $120 $37–$350 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Sanofi US Services Inc. $125 1 payment
  2. Stryker Corporation $116 1 payment
  3. Boston Scientific Corporation $48 1 payment
  4. Biosense Webster, Inc. $25 1 payment
  5. Pfizer Inc. $20 1 payment
  6. Novo Nordisk Inc $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $352 6 payments
Products named General payments · program years 2019–2023
  1. DUPIXENT $125 1 payment
  2. TARGET $116 1 payment
  3. SURPASS EVOLVE $116 1 payment
  4. TREVO $116 1 payment
  5. AXS VECTA 71 $116 1 payment
  6. EMBOLD Fibered $48 1 payment
  7. Acunav $25 1 payment
  8. ELIQUIS $20 1 payment
  9. NURTEC ODT $20 1 payment
  10. PAXLOVID $20 1 payment
  11. Other $34 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

148

Median for Family Practice: 1,826

Drug cost

$9,739

Median for Family Practice: $120,094

Branded share of claims

27%

Median for Family Practice: 18.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 15 $9,219
Metoprolol Succinate Generic 14 $143
Atorvastatin Calcium Generic 33 $104
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 14 $93
Amlodipine Besylate Generic 22 $63
Furosemide Generic 21 $54
Clopidogrel Clopidogrel Bisulfate Brand 11 $39
Prednisone Generic 18 $25

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$69,690

Medicare's payments for the services billed

Medicare patients

217

Average age 79

Services billed

720

127 women, 90 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 61%
Arthritis 57%
Heart failure 52%
Chronic kidney disease 51%
Diabetes 48%
Depression 48%
Alzheimer's or dementia 47%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

6 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record